You are viewing a free limited preview of 3-V Biosciences, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

3-V Biosciences, Inc.

Private Company Ticker Symbol™: (MVBIOSP)

Business Summary

3-V Biosciences, Inc. is a privately-held, venture capital backed biotechnology company that specializes in antiviral drugs to fight influenza. Founded in 2006 by Urs Greber, Dr. Lucas Pelkmans, and Prof. Ari Helenius, 3-V Biosciences, Inc. is headquartered in Palo Alto, California.

Overview & Corporate Organization

Basic Information

Company Tags:VC Backed
Year Founded:2006
Fiscal Year End:12/31
City:Menlo Park
State/Province:California
Country:United States
Phone:View
Website:www.3vbio.com

Industry Information

Industry Codes

PICS™:7008™, 1500109
NAICS:View
SIC:View

PrivCo Industries (Sector > Industry > Sub-Industry)

Healthcare > Pharmaceuticals
Technology > Biotechnology > Drug Delivery Technology

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

VC/Funding Activity

PrivCo's VC/Funding Activity table for 3-V Biosciences, Inc. displays the venture capital rounds, angel investments, debt or other funding raised by 3-V Biosciences, Inc..
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateInvestorRoundInvestor Type
Aug. 2009ViewBVenture Capital
Aug. 2009ViewBVenture Capital
Aug. 2009ViewBPrivate Equity & Venture Capital
DetailsTotal Round B View
May. 2010ViewCPrivate Equity & Venture Capital
DetailsTotal Round C View
Dec. 2011ViewOther
DetailsTotal Round Other1 View
Total of Funding Shown Above View
Notes
1According to an SEC filing,...Read More →
Full-length notes are available with Single Report Access or PrivCo Premium Subscription.

Missing a deal? Tell us about it! tips@privco.com

Supplemental Resources

For additional information on 3-V Biosciences, Inc., you can see the following:

You are viewing a free limited preview of 3-V Biosciences, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access